In filings with the state, insurance companies blamed the price increases on growing health care costs and increasing use of ...

Two of the largest health insurers, UnitedHealth ($UNH) and Elevance Health ($ELV), have informed Colorado regulators of ...

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...

In a separate setback, a federal judge ordered CVS Health’s Caremark unit to pay nearly $290 million in a Medicare fraud case. The court found that Caremark caused false information to be submitted to ...

A federal judge has ordered CVS Health's PBM Caremark to pay nearly $290 million after a whistleblower accused the business of overcharging Medicare on prescription drugs more than a decade ago.

CVS rejected coverage of Gilead's new HIV prevention drug Yeztugo, citing regulatory and financial factors, while facing nearly $290 million in Medicare overcharge penalties.